oral small molecules, vaccines, gene therapies)
1.1 Emerging role of dietary interventions Recent research suggests that certain dietary patterns can influence essential pathophysiological characteristics of AD, such as neuroinflammation, oxidative stress, and amyloid-beta deposition (Stefaniak et al., 2022)
Clinical trials such as the STEP program (semaglutide) and SURMOUNT trials (tirzepatide) demonstrate that patients typically experience reduced caloric intake, with many reporting decreased interest in food and smaller portion sizes
It improves mitochondrial function, reduces inflammation, enhances insulin sensitivity, and protects against oxidative stress
He felt better almost instantly